Form D · Pharmaceuticals
Juva Life, Inc.
San Jose, CA · CIK 0001760267
Offering snapshot reported Nov 29, 2018 · SEC filing
- Reported sold
- $5.45M Offering amount: $14.3M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $3.5K Reported outside-investor minimum
- First sale
- Nov 16, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2018 | Initial | $5,448,956 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $539K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-326832
Total offering amt includes $7.7MM of shares & warrants to purchase 11MM shares at $.60 per share offered to US persons under Rule 506 & foreign persons under Reg S. Total amt sold includes $661,576 sold to US persons. Item 14 only includes US persons.
Represents up to a 7% cash commission based on the total offering amt of $7,700,000. Warrants equal to 7% of the shares issued may also be paid as commission exercisable at $.60 per share.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Mackie Research Capital Corporation | None | |
| Haywood Securities Inc. | None | |
| Canaccord Genuity Corp. | None |
Source: Form D, filed Nov 29, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Douglas Chloupek | Director, Executive |
| Mathew Lee | Executive |
| Rakesh Patel | Director |
| Norton Singhavon | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2880 Zanker Road, Suite 203
San Jose, CA, 95134
San Jose, CA, 95134